Skip to content
Open access

NDM and OXA-48 Dominance among Carbapenem-Resistant Enterobacterales in an Indian Tertiary Care Hospital

Jul 2026 · EAS Journal of Parasitology and Infectious Diseases · Vol 8, pp. 73-79 · 0 citations

TL;DR

Genetic analysis revealed that blaNDM and blaOXA-48 were the most prevalent carbapenemase genes, while blaKPC and blaIMP occurred less frequently, suggesting the emergence of multidrug-resistant variants with complex resistance determinants.

Abstract

Carbapenem-resistant Enterobacterales (CRE) infections, which are associated with high morbidity and mortality, are increasingly reported worldwide, particularly in healthcare settings. This observational study investigated patients with CRE infections at an Indian tertiary care hospital. The infections predominantly affected elderly individuals: the 61–80 age group accounted for 59.4% of cases, while the 71–80 subgroup alone comprised 38.6% of patients. Regarding hospital stay duration, nearly half of the patients (48.3%) were hospitalized for 0–10 days, whereas 31.0% remained hospitalized for 31 days or more. The most frequently utilized indwelling devices were Foley catheters, followed by nebulizers, nasogastric (NG) tubes, and ventilators. Microbiologically, Klebsiella pneumoniae was the primary isolate (58.6%), followed by Escherichia coli (27.3%), Pseudomonas aeruginosa (6.1%), Acinetobacter baumannii (2.0%), non-lactose fermenters (2.0%), and Providencia rettgeri, Enterobacter cloacae, and Aspergillus spp. (2.0% each). This study highlights the clinical and microbiological characteristics of CRE isolated from hospitalized patients. Genetic analysis revealed that blaNDM and blaOXA-48 were the most prevalent carbapenemase genes, while blaKPC and blaIMP occurred less frequently. Notably, several isolates co-harbored multiple resistance genes (such as blaNDM and blaOXA-48, suggesting the emergence of multidrug-resistant variants with complex resistance determinants.

Read PDF

Similar papers

Open access Aug 2026

Activity of Aztreonam-avibactam and Ceftazidime-Avibactam against Enterobacterales and Pseudomonas aeruginosa causing infections in patients hospitalized in hematology, oncology, and transplant units from United States medical centres (2019-2024).

The antimicrobial susceptibility of Enterobacterales and Pseudomonas aeruginosa from patients hospitalized in hospital units where the frequency of immunosuppressed patients is very high is evaluated.

H. Sader, M. Castanheira, Todd Riccobene et al. · 0 citations
Open access Aug 2026

Infecciones por Acinetobacter baumannii resistente a carbapenémicos: descripción de cohorte de adultos mayores internados

Carbapenem-resistant Acinetobacter baumannii (ABA-RCB) infections represent a critical global threat due to their limited therapeutic options. This observational, analytical and retrospective study (2021-2024) evaluated the clinical, epidemiological profile and outcome of 57 patients with confirmed ABA-RCB infection in...

Micaela Sandoval, P. González, Juan Ignacio Rodriguez Lia et al. · 0 citations
Sep 2026

Appropriate Therapy and Survival in Carbapenem-Resistant Enterobacterales Bacteremia: A Multicenter Cohort Study on Epidemiology and Risk Factors.

In CRE bacteremia, combination therapy did not confer a uniform survival advantage, but was associated with lower mortality in patients receiving colistin-based regimens and those with high comorbidity burden.

Yae Jee Baek, Se Yoon Park, Jung Ho Kim et al. · 0 citations
Open access Sep 2026

Emerging ESBL and Carbapenem-resistance among Urinary Isolates in a Tertiary Care Setting

Gram-negative bacilli remain the predominant uropathogens in tertiary care settings, with an increasing burden of ESBL and carbapenem-resistance These findings underscore the need for continuous resistance surveillance, culture-guided therapy, and robust antimicrobial stewardship programs.

S. Ghogale, K. Pathak · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.